Finland· FI-REL-REL6029
Minims Cyclopentolate Hcl
A cyclopentolate product, registered in Finland by Chauvin Pharmaceuticals Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Cyclopentolate is registered in 16 of 19 countries.
Countries holding a registration under ATC S01FA04 (cyclopentolate), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Cyclopentolate · ATC S01FA04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Chauvin Pharmaceuticals Limited
- Country
- Finland (FI)
- ATC code
- S01FA04
- ATC class
- Cyclopentolate
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for cyclopentolate.
Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cyclopentolate · interactions on record
3 records
- 3 moderate
Most severe, free to view
- PhenylephrineC01CA06moderate
- PhysostigmineS01EB05moderate
- PhysostigmineV03AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01FA04
Cyclopentolate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3dcef457-df14-4a9b-ba68-de0c931b6349 GET /v1/drugs/3dcef457-df14-4a9b-ba68-de0c931b6349?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat",
"route": null,
"ddd_unit": null,
"strength": "5 mg/ml",
"atc_label": "syklopentolaatti",
"ma_number": "6553",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL6029",
"authorised_at": "1973-04-25"
}See everything about cyclopentolate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.